Novartis' repurposed leukemia drug tops Sanofi's Aubagio in MS study weeks ahead of FDA verdict

27th May 2020 Uncategorised 0

Novartis’ repurposed leukemia drug tops Sanofi’s Aubagio in MS study weeks ahead of FDA verdict
arlene.weintraub
Wed, 05/27/2020 – 09:36




More: Novartis' repurposed leukemia drug tops Sanofi's Aubagio in MS study weeks ahead of FDA verdict
Source: fierce